Monte Rosa Therapeutics, Inc. (GLUE)
10.81
+0.15
(+1.41%)
USD |
NASDAQ |
Oct 28, 13:44
Monte Rosa Therapeutics Price : 10.81 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 10.47 | 10.71 | 10.34 | 10.66 | 1.458M |
| Oct 26, 2026 | 10.94 | 10.94 | 10.32 | 10.48 | 1.227M |
| Oct 23, 2026 | 11.03 | 11.03 | 10.61 | 10.84 | 817827.0 |
| Oct 22, 2026 | 11.14 | 11.39 | 11.00 | 11.11 | 1.285M |
| Oct 21, 2026 | 11.38 | 11.74 | 11.08 | 11.22 | 1.080M |
| Oct 20, 2026 | 10.72 | 11.42 | 10.56 | 11.36 | 1.866M |
| Oct 19, 2026 | 9.84 | 10.71 | 9.76 | 10.66 | 1.926M |
| Oct 16, 2026 | 10.18 | 10.23 | 9.705 | 9.74 | 885433.0 |
| Oct 15, 2026 | 9.95 | 10.24 | 9.88 | 10.12 | 1.544M |
| Oct 14, 2026 | 9.76 | 10.10 | 9.71 | 9.84 | 1.093M |
| Oct 13, 2026 | 10.45 | 10.54 | 9.852 | 9.89 | 2.714M |
| Oct 12, 2026 | 10.29 | 10.63 | 10.14 | 10.52 | 2.095M |
| Oct 09, 2026 | 10.36 | 10.52 | 10.21 | 10.30 | 1.202M |
| Oct 08, 2026 | 10.04 | 10.38 | 9.82 | 10.32 | 1.887M |
| Oct 07, 2026 | 9.84 | 10.75 | 9.68 | 10.17 | 2.082M |
| Oct 06, 2026 | 10.38 | 10.38 | 9.78 | 9.87 | 1.053M |
| Oct 05, 2026 | 10.56 | 10.59 | 10.04 | 10.27 | 1.749M |
| Oct 02, 2026 | 11.40 | 11.40 | 10.32 | 10.50 | 2.215M |
| Oct 01, 2026 | 12.15 | 12.26 | 11.07 | 11.26 | 2.869M |
| Sep 30, 2026 | 11.85 | 12.15 | 11.65 | 11.93 | 913959.0 |
| Sep 29, 2026 | 11.68 | 12.17 | 11.56 | 11.74 | 545068.0 |
| Sep 28, 2026 | 11.69 | 11.98 | 11.50 | 11.71 | 772655.0 |
| Sep 25, 2026 | 11.75 | 11.89 | 11.62 | 11.77 | 802136.0 |
| Sep 24, 2026 | 11.93 | 12.00 | 11.42 | 11.72 | 1.144M |
| Sep 23, 2026 | 12.60 | 12.61 | 11.70 | 11.89 | 1.176M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 586.25 |
| ACADIA Pharmaceuticals, Inc. | 20.32 |
| Alnylam Pharmaceuticals, Inc. | 228.09 |
| Anika Therapeutics, Inc. | 21.49 |
| Savara, Inc. | 4.925 |
Price Related Metrics
| PS Ratio | 32.86 |
| Price to Book Value | 1.891 |
| Earnings Yield | -17.63% |
| Market Cap | 921.30M |